title: [Evaluating thyroid gland function in patients with protein anomalies].
abstract: The euthyroid hyperthyroxinemia (EHT) is characterized on the one hand by a normal basal THS or TRH-TSH response but also by high plasma values of total thyroxine (TT4) on the other. However if only TT4 is assessed, "hyperthyroidism" may be diagnosed erroneously. EHT may be caused by an increase of specific thyroxine binding proteins which may be hereditary (permanent) or acquired (transient). The most frequent disturbance is due to an estrogen induced increase of thyroxine binding globulin (TBG) in the course of pregnancy, anticonceptive drugs or estrogen treatment. The albumin associated HT (FDH syndrome), first reported in 1979, has autosomal dominant traits. 144 patients with FDH syndrome were observed during the period between 1984 and 1990, i.e. 7% (1986) of all hyperthyroid patients explored. Family screening is required to prevent unjustified treatment. Additionally existing disturbances of thyroid function as well as other protein binding anomalies may both cause problems in differential diagnosis. Prealbumin associated hyperthyroxinemia (PAAH), first published in 1982, may be due to an inherited increase in affinity, but may also be the consequence of a true elevation of prealbumin plasma concentration in the course of an islet cell cancer; both conditions are extremely rare. Nearly as rare are patients with plasma autoantibodies directed against T4 and/or T3 (5 cases); yet, a reverse T3 autoantibody could be observed in merely 1 case. By means of our modified radio-thyroxine-agarosegel-iceelectrophoresis all such protein anomalies may be diagnosed and differentiated in 1 procedure. Moreover, all other types of EHT must be taken into consideration by differential diagnosis.
authors.affiliation: Internen Abteilung, Krankenhauses der Barmherzigen Brüder, Graz-Eggenberg.
authors.forename: O
authors.initials: O
authors.lastname: Eber
authors.forename: W
authors.initials: W
authors.lastname: Langsteger
authors.forename: W
authors.initials: W
authors.lastname: Florian
authors.forename: B
authors.initials: B
authors.lastname: Schubert
authors.forename: P
authors.initials: P
authors.lastname: Lind
authors.forename: G
authors.initials: G
authors.lastname: Klima
authors.forename: O
authors.initials: O
authors.lastname: Wawschinek
mesh_terms: D001796:Blood Protein Disorders / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D003937:Diagnosis, Differential; D005067:Euthyroid Sick Syndromes / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000175:diagnosis* / Q000235:genetics; D006981:Hyperthyroxinemia / Q000097:blood / Q000175:diagnosis / Q000235:genetics; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone; D013974:Thyroxine / Q000097:blood; D013975:Thyroxine-Binding Proteins / Q000235:genetics / Q000378:metabolism
chemical_list: D013975:Thyroxine-Binding Proteins; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013974:Thyroxine
vernacular_title: Beurteilung der Schilddrüsenfunktion bei Patienten mit Proteinanomalien.